Curis | CRIS - Spese Operative





Spese Operative Cambiamento Data
Alaunos Therapeutics USD 1.19M 148K 2025-09
Amgen USD 5.9B 773M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bayer EUR 10.33B 126M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
CSL USD 5.7B 2.82B 2025-12
Curis USD 9.02M 23.01M 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Incyte USD 1.12B 3.53B 2025-12
Merck USD 10.16B 558M 2025-12
Novartis USD 9.8B 61M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Takeda JPY 1.02T 400.98B 2025-12
TG Therapeutics USD 142.08M 9.74M 2025-12
Verastem USD 59.01M 21.98M 2025-12
Xoma USD 22.84M 1.67M 2024-09